AI Article Synopsis
- Hand-foot syndrome (HFS) is an adverse effect of chemotherapy that causes discomfort and redness primarily on the palms and soles of the feet.
- Paclitaxel, though an uncommon cause of HFS, can manifest in an unusual way on the dorsal (top) surfaces of the hands and feet.
- A case is presented involving a 66-year-old man with metastatic angiosarcoma experiencing HFS on his dorsal hands, highlighting the importance of early detection and management to maintain chemotherapy and enhance the patient's quality of life.
Article Abstract
Hand-foot syndrome (HFS), also known as palmoplantar erythrodysesthesia or acral erythema, is a known adverse effect of chemotherapeutic agents that most commonly presents as palmoplantar dysesthesia and erythematous plaques localized to the palms and soles. Paclitaxel is an uncommon cause of HFS and is notable for its unique presentation on the dorsal hands and feet. We present an unusual case of paclitaxel-induced HFS localized to the dorsal hands of a 66-year-old man with metastatic angiosarcoma. Early identification and management of HFS is critical to allow for continuation of chemotherapy while improving patient quality of life.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5070/D329361434 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!